SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 124 filers reported holding SERES THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,769,047 | -50.2% | 19,230,692 | +0.2% | 0.00% | -50.0% |
| Q2 2023 | $91,897,147 | -57.1% | 19,185,208 | -49.3% | 0.01% | -20.0% |
| Q1 2023 | $214,455,934 | +104.9% | 37,822,916 | +102.4% | 0.01% | 0.0% |
| Q4 2022 | $104,657,061 | -12.4% | 18,688,761 | +0.4% | 0.01% | -16.7% |
| Q3 2022 | $119,481,000 | +87.3% | 18,610,733 | +0.1% | 0.01% | +100.0% |
| Q2 2022 | $63,802,000 | -35.4% | 18,601,212 | +34.0% | 0.01% | -25.0% |
| Q1 2022 | $98,810,000 | -13.9% | 13,877,865 | +0.7% | 0.01% | 0.0% |
| Q4 2021 | $114,763,000 | +19.9% | 13,777,070 | +0.1% | 0.01% | 0.0% |
| Q3 2021 | $95,755,000 | -68.9% | 13,757,785 | +6.5% | 0.01% | -66.7% |
| Q2 2021 | $308,120,000 | +21.9% | 12,919,073 | +5.2% | 0.02% | +9.1% |
| Q1 2021 | $252,859,000 | -9.0% | 12,280,673 | +8.3% | 0.02% | -12.0% |
| Q4 2020 | $277,746,000 | -8.5% | 11,336,573 | +5.8% | 0.02% | -19.4% |
| Q3 2020 | $303,410,000 | +1010.1% | 10,717,400 | +86.6% | 0.03% | +933.3% |
| Q2 2020 | $27,332,000 | +24.5% | 5,742,076 | -6.6% | 0.00% | 0.0% |
| Q1 2020 | $21,955,000 | -2.1% | 6,149,746 | -5.4% | 0.00% | +50.0% |
| Q4 2019 | $22,422,000 | -21.8% | 6,499,118 | -9.1% | 0.00% | -33.3% |
| Q3 2019 | $28,667,000 | +9.9% | 7,148,846 | -11.8% | 0.00% | 0.0% |
| Q2 2019 | $26,088,000 | -34.8% | 8,101,946 | +39.2% | 0.00% | -40.0% |
| Q1 2019 | $39,998,000 | +44.4% | 5,822,145 | -5.0% | 0.01% | +25.0% |
| Q4 2018 | $27,700,000 | -40.4% | 6,128,386 | +0.1% | 0.00% | -20.0% |
| Q3 2018 | $46,446,000 | -11.4% | 6,119,349 | +0.4% | 0.01% | -16.7% |
| Q2 2018 | $52,422,000 | +17.2% | 6,095,600 | +0.0% | 0.01% | +20.0% |
| Q1 2018 | $44,737,000 | -27.4% | 6,094,953 | +0.3% | 0.01% | -28.6% |
| Q4 2017 | $61,623,000 | -36.8% | 6,077,221 | +0.0% | 0.01% | -41.7% |
| Q3 2017 | $97,437,000 | +42.4% | 6,074,596 | +0.3% | 0.01% | +33.3% |
| Q2 2017 | $68,436,000 | +0.3% | 6,056,294 | +0.1% | 0.01% | 0.0% |
| Q1 2017 | $68,216,000 | +13.9% | 6,052,919 | +0.0% | 0.01% | +12.5% |
| Q4 2016 | $59,906,000 | -19.3% | 6,051,063 | +0.2% | 0.01% | -20.0% |
| Q3 2016 | $74,218,000 | -56.9% | 6,038,875 | +1.9% | 0.01% | -58.3% |
| Q2 2016 | $172,207,000 | +10.3% | 5,927,976 | +0.8% | 0.02% | +9.1% |
| Q1 2016 | $156,122,000 | -24.1% | 5,878,052 | +0.3% | 0.02% | -21.4% |
| Q4 2015 | $205,570,000 | +18.7% | 5,858,365 | +0.2% | 0.03% | +12.0% |
| Q3 2015 | $173,233,000 | -20.3% | 5,844,546 | +11.6% | 0.02% | -10.7% |
| Q2 2015 | $217,396,000 | – | 5,238,465 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $55,018,567 | 3.99% |
| Lion Point Capital, LP | 691,803 | $1,646,491 | 0.73% |
| Eversept Partners, LP | 2,352,556 | $5,599,083 | 0.47% |
| Soleus Capital Management, L.P. | 1,820,983 | $4,333,940 | 0.40% |
| Simplify Asset Management Inc. | 550,626 | $1,310,490 | 0.15% |
| Avoro Capital Advisors LLC | 2,500,000 | $5,950,000 | 0.09% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 45,419 | $108,097 | 0.07% |
| Knott David M Jr | 70,000 | $167 | 0.06% |
| XTX Topco Ltd | 150,097 | $357,231 | 0.06% |
| FEDERATED HERMES, INC. | 8,981,717 | $21,376,486 | 0.06% |